Lars Rombo

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Anthony L. Cunningham, Himal Lal, Martina Kovac et al. · New England Journal of Medicine · 2016 · 1K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee et al. · The Lancet Infectious Diseases · 2019 · 254 citations · Full text

Veterinary Medicine, Immunology, Oncology +16

Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study

Roman Chlíbek, Jan Smetana, Karlis Pauksens et al. · Vaccine · 2014 · 136 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults

Roman Chlíbek, Karlis Pauksens, Lars Rombo et al. · Vaccine · 2015 · 122 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

Ana Strezova, Javier Díez‐Domingo, Kamal Al Shawafi et al. · Open Forum Infectious Diseases · 2022 · 101 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17